Concepedia

Inge Schwersenz

IS

Statistics

Publications

4

Citations

345

H-Index

4

Active since

2017

Affiliations

Deutsche Gesellschaft für Muskelkranke(Current)

University of Freiburg

Association Francaise contre les Myopathies

Children's Hospital of Eastern Ontario

University of Ottawa

Inge Schwersenz is an author at Deutsche Gesellschaft für Muskelkranke specializing in nusinersen therapy, spinal muscular atrophy, and pediatric neuromuscular disorders.

Publications per year

2017–2022

4

Publications

4

SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy

Astrid Pechmann, Kirsten König, Günther Bernert et al. · Orphanet Journal of Rare Diseases · 2019 · 140 citations · Full text

, , +14

Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients

Françoise Rouault, Vanessa Christie-Brown, Ria Broekgaarden et al. · Neuromuscular Disorders · 2017 · 125 citations

, , +14

Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy

Astrid Pechmann, Max Behrens, Katharina Dörnbrack et al. · Brain · 2022 · 70 citations · Full text

, , +15

Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients

Hanns Lochmüller, David Evans, Wildon Farwell et al. · Journal of Neuromuscular Diseases · 2018 · 10 citations · Full text

, , +11

1–4 of 4